Beta Bionics Rings the Opening Bell

About This Event

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the design, development of advanced diabetes management solutions, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Sean Saint, Chief Executive Officer, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore